Influenza Vaccination and Risk of Stroke in Older Adults
Drug Topics
SEPTEMBER 30, 2024
Researchers addressed the association between older individuals who received an influenza vaccine and their risk of stroke following vaccination.
Mon.Sep 30, 2024
192 
Marburg virus outbreak in Rwanda draws concern over possibility of international spread
STAT
SEPTEMBER 30, 2024
A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the country’s borders. The number of cases detected so far, 27 , already makes the outbreak one of the biggest involving Marburg on record. Nine of those individuals have died. There are currently no licensed vaccines to combat the disease.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Impact of Stigma on Pharmacists with SUD, Importance of Mental Health Care
Drug Topics
SEPTEMBER 30, 2024
Sara T. Thomason discuses the impact of stigma on pharmacists who are dealing with substance use disorder, the importance of mental health care, and how schools support pharmacy students dealing with addiction.
STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion
STAT
SEPTEMBER 30, 2024
Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs even lost their bonuses. But the biggest names in health care still made $3.5 billion combined last year, compared with $4 billion in 2022. The average chief executive brought home $11 million, while the median was $4.1 million.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Guideline-Directed Medical Therapy Improves Outcomes in HFrEF
Drug Topics
SEPTEMBER 30, 2024
Left ventricular ejection fraction, brain natriuretic peptide, and heart failure-related hospitalizations were among the improved metrics.
Managing and Monitoring Cardiotoxic Risks During Cancer Treatment
Pharmacy Times
SEPTEMBER 30, 2024
Aaron Adkisson, PharmD, discusses the importance of considering factors such as age, gender, and cardiovascular comorbidities when monitoring and managing cardiotoxic risks in patients with cancer. also emphasizing patient education on recognizing early heart failure symptoms.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Expert: Patients With C. difficile Can Have Difficulty Advocating For Themselves
Pharmacy Times
SEPTEMBER 30, 2024
C. diff survivor and Peggy Lillis Foundation Board Member Maryann Webb discusses how her experience with the infection encouraged her to advocate for patients who are struggling to advocate for themselves.
Register Today: October 2024 Total Pharmacy Solutions Summit
Drug Topics
SEPTEMBER 30, 2024
The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.
FDA Grants Rare Pediatric Disease Designation to MDL-101 for Congenital Muscle Dystrophy
Pharmacy Times
SEPTEMBER 30, 2024
MDL-101 is a proposed novel precision medicine that targets the LAMA1 gene, causing LAMA2 congenital muscular dystrophy type 1a.
STAT+: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
STAT
SEPTEMBER 30, 2024
Prime Medicine, founded with gene-editing tech from the lab of star Harvard biochemist David Liu and backed by blue chip investors, made little secret of its ambition. It laid out plans to use its new gene-editing technology across 18 different diseases, listing conditions as disparate as ALS, congenital blindness, and muscular dystrophy.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
With Medicare's annual enrollment period 2 weeks away, here's what major payers will have on offer
Fierce Healthcare
SEPTEMBER 30, 2024
As the calendar turns to October, the health insurance industry is gearing up for Medicare's annual enrollment period. | As the calendar turns to October, the health insurance industry is gearing up for Medicare's annual enrollment period.
American Pharmacists Month: Pharmacy Owner Talks Changes, Rewarding Aspects of Profession
Pharmacy Times
SEPTEMBER 30, 2024
Alan Corley, pharmacy owner in Greenville, TN, reflects on the changes he's witnessed throughout his career and the most rewarding aspects of his profession.
Higher Vaccination Rates Improve Outcomes in Heart Failure During Respiratory Virus Season
Drug Topics
SEPTEMBER 30, 2024
Vaccination against respiratory viruses such as RSV and the flu are crucial to prevent adverse outcomes in patients with heart failure.
CDMOs eye industrywide growth in 2025 as many spurn BIOSECURE Act, CPHI research shows
Fierce Pharma
SEPTEMBER 30, 2024
After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound in 2025. | Ahead of the CPHI conference in Milan, the events group has teased new research signaling an expected rebound for the CDMO industry—and a rejection of the BIOSECURE Act.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pandemic-Related Hospital Caseload Strain Attributes to Portion of COVID-19 Deaths
Pharmacy Times
SEPTEMBER 30, 2024
There was a detrimental relationship between COVID-19 caseload and mortality observed across multiple types of hospitals.
J&J, Legend solidify Carvykti's lead in earlier multiple myeloma with strong survival showing
Fierce Pharma
SEPTEMBER 30, 2024
After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson & Johnson and Legend Biotech’ Carvykti has once again mounted a maj | After putting on a strong performance in preventing disease progression, Johnson & Johnson and Legend Biotech’s Carvykti has once again demonstrated a major benefit—this time in prolonging patients’ lives.
STAT+: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund
STAT
SEPTEMBER 30, 2024
DCVC Bio, a Silicon Valley area investment firm launched six years ago by a group of tech, bio, and agriculture investors, has raised a new $400 million fund, it told STAT exclusively. This is the third fund DCVC Bio has raised. It came in ahead of the original $350 million goal, according to executives. The announcement makes DCVC Bio one of a select number of biotech VCs to raise new pools of capital this year.
American Academy of Pediatrics Releases First Clinical Practice Guideline for Opioid Prescription, Treatment
Pharmacy Times
SEPTEMBER 30, 2024
The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.
STAT+: Q&A: Why medical AI and value-based care may be made for each other
STAT
SEPTEMBER 30, 2024
At last count, the Food and Drug Administration has authorized 950 medical devices that use artificial intelligence and machine learning. But far fewer have made a significant impact on patient care in the United States. For medical AI developers like James Zou, that’s a problem. The Stanford professor is invested in getting effective medical machine learning — including some of his own, FDA-cleared algorithms — adopted by health systems.
Key investor pressing CVS' leadership for strategic changes: report
Fierce Healthcare
SEPTEMBER 30, 2024
A key hedge fund investor for CVS Health will meet with the company's top brass today in a move that signals a potential activist approach going forward,
How do you stop acid reflux on Ozempic?
The Checkup by Singlecare
SEPTEMBER 30, 2024
Ozempic (active ingredient semaglutide) is a GLP-1 receptor agonist that is FDA approved to manage Type 2 diabetes in adults in conjunction with a reduced-calorie diet and regular exercise. Like other medications in its class, such as Wegovy and Mounjaro , Ozempic mimics the actions of GLP-1, a hormone that controls appetite and stimulates insulin release.
STAT+: Roche seeks to project confidence on its obesity drugs — and sees room for competition
STAT
SEPTEMBER 30, 2024
LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ products — and that the huge demand for effective weight loss drugs means there is room for another company in the field. “We wouldn’t have moved forward with these assets if we didn’t feel they were differentiated,” including in their molecular makeup and how they could be used in combination with other treatmen
Improving Luspatercept Dosing for Patients With MDS: The Impact of Pharmacist-Led Interventions at AON
Pharmacy Times
SEPTEMBER 30, 2024
Brooke Peters, PharmD, BCOP, discusses a study conducted at American Oncology Network (AON) to evaluate luspatercept dosing for patients with low- to intermediate-risk myelodysplastic syndromes (MDS).
Preventing burnout and optimising pharmacist time with AI
pharmaphorum
SEPTEMBER 30, 2024
Find out how AI can help prevent burnout and optimise pharmacist time in the pharmacy setting. Learn how technology can streamline processes and improve efficiency in this crucial healthcare profession.
Cost-Benefit Analysis Favors RSV Vaccination for Older Adults
Drug Topics
SEPTEMBER 30, 2024
Investigators suggested that the future cost-effectiveness of respiratory syncytial virus (RSV) vaccination could be improved through lower vaccine prices and longer-lasting protection.
After landmark rare disease approval, IntraBio ready to 'hit the ground running' with Aqneursa launch
Fierce Pharma
SEPTEMBER 30, 2024
With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. | With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ultra-rare disease. Still, with months of prep work and outreach complete, the company is already proving it can hit the ground running.
Pain Management Roundup: Addressing Gaps with Cebranopadol, Navigating Nephrolithiasis
Drug Topics
SEPTEMBER 30, 2024
Catch up on important pain management news from the month of September 2024.
After scoring a first for an off-the-shelf CAR-T, can Atara maintain momentum?
PharmaVoice
SEPTEMBER 30, 2024
The company’s allogeneic therapy was OK’d in the EU and could become the first of its kind approved by the FDA in January — while eyeing the next frontier.
STAT+: How much more are health care’s bosses making than their employees?
STAT
SEPTEMBER 30, 2024
How much health care’s bigwigs are making Mike Reddy for STAT Health care stocks lagged behind the broader market in 2023, and that was reflected in many CEO pay packages. My colleagues and I completed our annual tradition of analyzing CEO compensation. For 2023, we input data for 313 health care CEOs and found they made $3.5 billion combined last year , compared with $4 billion in 2022.
The Latest Surrounding Rising Medicare Part D Premiums
Pharmaceutical Commerce
SEPTEMBER 30, 2024
Why looming benefit changes—and the resulting unintended consequences—are a concern for patients.
Morning Rounds: How much did health care’s top-earning CEO make in 2023?
STAT
SEPTEMBER 30, 2024
Good morning! What would you buy if you earned $305 million in one year? Maybe I’d have a different color KitchenAid mixer for every season. Bird flu: More questions than answers as more health worker sickness is revealed An investigation into a still unexplained human case of bird flu in Missouri has turned up four more health care workers who developed mild respiratory symptoms after caring for the patient, the CDC reported on Friday.
Victor Alves Presenting at the 2024 Northeast Conference
OctariusRx
SEPTEMBER 30, 2024
OctariusRx President and Consultant Pharmacist Victor Alves is presenting “Medication management when done right, keeps patient harm and deficiencies out of sight” at the 2024 Northeast Conference, presented by the Massachusetts Association of Ambulatory Surgery Centers. He will discuss the basics of safe medication management, as well as more advanced concepts.
A radiopharmaceuticals startup raises $175 million
STAT
SEPTEMBER 30, 2024
This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Hello! Today, we talk about how much dang money some CEOs still make, despite the slowdown in the biotech industry. We also see Dupixent approved for a huge new indication, and more.
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy
pharmaphorum
SEPTEMBER 30, 2024
Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy Nicole.
Let's personalize your content